Main Menu

Centre for Molecular Pathology

The Centre for Molecular Pathology is a collaborative initiative between The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, aiming identify the molecular mechanisms that drive cancers and to target them with a new generation of treatments.

The Centre for Molecular Pathology (Joe Dunckley for the ICR, 2013)

The new, purpose-built centre on the Sutton site provides an innovative environment with state of the art laboratories, bringing together world experts in molecular pathology, bioinformatics and translational research.

The centre’s research objectives aim to expedite the process by which personalised medicine is embedded as a routine part of cancer care for patients. The focus will be to develop molecular diagnostics and biomarkers for cancer, to allow patient treatment to be personalised. Researchers aim to identify reliable biomarkers of disease prognosis or treatment response, and new molecular targets for a range of tumour types. This will drive the development of novel anti-cancer drugs.

The Centre for Molecular Pathology is funded through the National Institute for Health Research Biomedical Research Centre at The Royal Marsden and the ICR – the only specialist Biomedical Research Centre for Cancer.

We use cookies to ensure that we give you the best experience on our website. By continuing to use this website, you are agreeing to our use of cookies on your device as described in our cookie policy. You can change your cookie settings at any time but parts of our site will not function correctly without them.